Quantified Mobile Sensing for Improving Diagnosis and Measuring Disease Progression

Completed

Conditions studied: Depression, Bipolar Disorder

In brief

The purpose of this study is to determine if a mobile sensing platform can passively and objectively detect the presence of clinically significant mood disorder symptomatology and symptom progression over time. Meeting this goal will allow for improved risk categorization, prediction of relapse, and measurement of disease progression in a lifetime prevalence population.

Key facts

Study ID

NCT02742064

Run by

Cogito Health Inc

People needed

899

Starts

2015-02-01

Expected to finish

2018-03-31

Last updated by the study team

2018-07-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 or older
• Have a smartphone and cell service plan, including voice and data, that meets the device requirements of the Mobile Sensing Platform.
• Enrolled in the MoodNetwork

You may not qualify if…

• Report positively on the QIDS-SR suicide item during study intake
• Total score greater than 15 on the QIDS-SR during the screening process

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.